- Home
- WPM vs EW Comparison
WPM vs EW Comparison
Compare WPM & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WPM
- EW
- Stock Information
- Founded
- WPM 2004
- EW 1958
- Country
- WPM Canada
- EW United States
- Employees
- WPM N/A
- EW N/A
- Industry
- WPM Precious Metals
- EW Industrial Specialties
- Sector
- WPM Basic Materials
- EW Health Care
- Exchange
- WPM Nasdaq
- EW Nasdaq
- Market Cap
- WPM 40.9B
- EW 44.8B
- IPO Year
- WPM 2004
- EW 2000
- Fundamental
- Price
- WPM $91.04
- EW $78.10
- Analyst Decision
- WPM Strong Buy
- EW Buy
- Analyst Count
- WPM 8
- EW 20
- Target Price
- WPM $87.88
- EW $80.40
- AVG Volume (30 Days)
- WPM 1.7M
- EW 3.5M
- Earning Date
- WPM 08-07-2025
- EW 07-24-2025
- Dividend Yield
- WPM 0.70%
- EW N/A
- EPS Growth
- WPM 4.62
- EW 200.69
- EPS
- WPM 1.36
- EW 7.02
- Revenue
- WPM $1,458,244,000.00
- EW $5,522,300,000.00
- Revenue This Year
- WPM $38.25
- EW $11.81
- Revenue Next Year
- WPM $2.93
- EW $9.54
- P/E Ratio
- WPM $66.82
- EW $11.11
- Revenue Growth
- WPM 32.76
- EW 8.23
- 52 Week Low
- WPM $53.05
- EW $58.93
- 52 Week High
- WPM $95.23
- EW $95.25
- Technical
- Relative Strength Index (RSI)
- WPM 54.98
- EW 58.61
- Support Level
- WPM $85.59
- EW $75.84
- Resistance Level
- WPM $92.76
- EW $78.90
- Average True Range (ATR)
- WPM 2.65
- EW 1.48
- MACD
- WPM -0.21
- EW 0.15
- Stochastic Oscillator
- WPM 76.01
- EW 85.51
About WPM Wheaton Precious Metals Corp (Canada)
Wheaton Precious Metals Corp is a precious metal streaming company. The company metal streaming company which generates its revenue primarily from the sale of precious metals (gold, silver and palladium) and cobalt. Its reportable segment includes: Gold, Silver, Palladium, Platinum, Cobalt, and Other.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.